Revised guidelines for risk stratification in mgus to reduce overdiagnosis In oncology, bristol myers squibb’s iberdomide and mezigdomide aim to replace older myeloma. Also, find out the outcome of the recent oncologic drugs advisory committee (odac.
Ivonne Fitness | Instagram, Facebook, TikTok | Linktree
Ninlaro is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
The treatment of relapsed/refractory multiple myeloma (mm) has evolved to include several new options
These include new combinations with second generation proteasome inhibitors (pi) Second generation immunomodulators, monoclonal antibodies, car t cells, bispecific antibodies, selinexor, venetoclax, and many others Most patients with mm undergo several cycles of remissions and relapse, and. During the session “advancing care for multiple myeloma
Strategies for integrating bispecific antibodies in clinical practice,” moderator nicholas bouchard, pharmd, guided a discussion that.
